CSIMarket
 


Biofrontera Ag  (BFRA)
Other Ticker:  
 

Cumulative Biofrontera Ag's Quick Ratio for Trailing Twelve Months Period

BFRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

BFRA Quick Ratio for Trailing Twelve Months Period

(Dec 31 2018)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Growth - - - - -
Y / Y Cash & cash equivalent Growth - - - - -
Quick Ratio for Trailing Twelve Months Period 2.5 2.5 2.5 2.5 -
Total Ranking # 923 # # # #
Seq. Current Liabilities Growth 0 % 0 % 0 % - -
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % - -


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2018
On the trailing twelve months basis Despite unchange in Current Liabilities in the IV. Quarter to $9 millions, average cumulative Quick Ratio for Trailing Twelve Months Period remained unchanged at 2.5 below Biofrontera Ag average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 255 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Biofrontera Ag. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about BFRA
Quick Ratio BFRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 256
Sector # 414
S&P 500 # 885


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.5 2.5 2.5
(Dec 31 2018)  




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Infinity Pharmaceuticals Inc   6.88 
Zynerba Pharmaceuticals Inc   6.86 
Clovis Oncology inc   6.76 
Acadia Pharmaceuticals Inc   6.75 
Progenics Pharmaceuticals Inc  6.68 
Cnbx Pharmaceuticals Inc   6.64 
Arqule Inc  6.63 
Nabriva Therapeutics Plc  6.60 
Syndax Pharmaceuticals Inc   6.60 
Xoma Corporation  6.48 
Arvinas Inc   6.48 
Pacira Biosciences inc   6.47 
Ultragenyx Pharmaceutical Inc   6.44 
Ensysce Biosciences Inc   6.44 
Zai Lab Limited  6.43 
Esperion Therapeutics inc   6.43 
Aileron Therapeutics Inc   6.42 
Benitec Biopharma Inc   6.32 
Carisma Therapeutics Inc   6.30 
Calithera Biosciences Inc   6.29 
Ionis Pharmaceuticals Inc  6.25 
Vistagen Therapeutics Inc   6.19 
Lixte Biotechnology Holdings Inc   6.19 
Protagonist Therapeutics inc   6.16 
Vascular Biogenics Ltd   6.15 
Reata Pharmaceuticals Inc   6.12 
Immutep Limited  6.09 
Journey Medical Corporation  6.09 
Genprex Inc   5.94 
Ocuphire Pharma Inc   5.91 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com